Skip to content

Facebook-f Twitter Youtube

847-881-5090
jingyang@aplexis.net

Menu

Home
Pipeline
Technology
Team
News
Contact

Pipeline

Pipeline

Plek2 inhibitor for the treatment of myeloproliferative neoplasms
Plek2 inhibitor for the treatment of solid cancers

Aplexis is a start-up biopharmaceutical company focusing on the development of small molecule inhibitors to treat myeloproliferative neoplasms.

Menu

Home
Pipeline
Technology
Team
News
Contact

Menu

Home
Pipeline
Technology
Team
News
Contact

Copyright © 2023 Aplexis, Inc. | All Right Reserved.

Scroll to Top